+424.6%
THC vs AVAV
-14.7%
+439.3%
-34.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | AVAV | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.0% | -9.8% | +7.9% | -1.4% |
| 7D | +5.9% | -24.3% | +30.2% | +7.5% |
| 30D | +10.8% | -28.9% | +39.7% | +12.9% |
| 3M | +9.4% | -39.3% | +48.7% | +12.4% |
| 6M | +53.3% | -38.8% | +92.0% | +55.8% |
| YTD | +44.2% | -57.8% | +102.0% | +49.1% |
| 1Y | +37.3% | -70.9% | +108.2% | +49.2% |
| All | +424.6% | -14.7% | +439.3% | +336.1% |
Cumulative growth
Daily Returns
Daily percentage return beside AVAV.
Daily Out/Under-Performance
Portfolio return minus AVAV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AVAV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded AVAV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling